Immunolocalization of glycoprotein A-80 in prostatic carcinoma and prostatic intraepithelial neoplasia

Human Pathology

Volumn 27, Issue 6, 1996, Pages 547-552

  Gould, Victor E ^a   Doljanskaia, Vera ^b   Gooch, Gary ^b   Bostwick, David G ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

A 80; glycoproteins; immunohistochemistry; mucins; prognosis; prostate; prostatic carcinoma; prostatic intraepithelial neoplasia

Indexed keywords

GLYCOPROTEIN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CANCER GRADING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATE TUMOR; PROSTATECTOMY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE SECTION; TRANSURETHRAL RESECTION;

EID: 0029940968     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90160-4     Document Type: Article

References (66)

1. Koprowski H, Herlyn M, Steplewski Z, et al: Specific antigen in serum of patients with colon carcinoma. Science 212:53-55, 1981
2. Klug TL, Bast RC Jr, Niloff JM, et al: Monoclonal antibody immunoradiometric assay for antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Res 44:1048-1053, 1984
3. Holmgren J, Lindholm L, Persson B, et al: Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. Br Med J 288:1479-1482, 1984
4. Metzgar RS, Rodriguez N, Finn OJ, et al: Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci U S A 81:5242-5246, 1984
5. Herlyn M, Sears HF, Verrill H, et al: Increased sensitivity in detecting tumor-associated antigens in sera of patients with colorectal carcinoma. J Immunol Methods 75:15-21, 1985
6. a for serological tests of cancer. Cancer Res 45:435-437, 1985
7. Papsidero LD, Nemoto T, Croghan GA, et al: Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22. Cancer Res 44:4653-4657, 1984
8. Nuti M, Teramoto YA, Mariani-Constantini NR, et al: A monoclonal antibody (B72.3) defined patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations. Intl J Cancer 29:539-545, 1982
9. Miotti S, Aguanno S, Canevari S, et al: Biochemical analysis of human ovarian cancer-associated antigens defined by murine monoclonal antibodies. Cancer Res 45:826-832, 1985
10. Chung YS, Ho JJ, Kim YS, et al: The detection of human pancreatic cancer-associated antigen in the serum of patients. Cancer 60:1636-1643, 1987
11. Radosevich JA, Ma Y, Lee I, et al: Monoclonal antibody 44-3A6 as a probe for a novel antigen found in human carcinomas with glandular differentiation. Cancer Res 45:5808-5813, 1985
12. Lee I, Radosevich JA, Ma Y, et al: Immunohistochemical analysis of human pulmonary carcinomas using monoclonal antibody 44-3A6. Cancer Res 45:5813-5817, 1985
13. Lee I, Radosevich JA, Chejfec G, et al: Malignant mesotheliomas: Improved differential diagnosis from lung adenocarcinoma using monoclonal antibody 44-3A6. Am J Pathol 123:497-507, 1986
14. Piehl MR, Gould VE, Warren WH, et al: Immunohistochemical identification of exocrine and neuroendocrine subsets of large cell lung carcinomas. Pathol Res Pract 183:675-682, 1988
15. Rittenhouse HG, Manderino GL, Hass GM: Mucin-type glycoproteins as tumor markers. Lab Med 16:556-560, 1985
16. Gould VE, Shin SS, Manderino GL, et al: Selective expression of a novel mucin-type glycoprotein in human tumors: Immunohistochemical demonstration with Mab A-80. Hum Pathol 19:623-627, 1988
17. Jansson DS, Gould VE, Gooch GT, et al: Immunohistochemical analysis of colon carcinomas applying exocrine and neuroendocrine markers. APMIS 96:1129-1139, 1988
18. Shin SS, Gould VE, Gould JE, et al: Expression of a new mucin-type glycoprotein in select epithelial dysplasias and neoplasms detected immunocytochemically with Mab A-80. APMIS 97:1053-1067, 1989
19. Koukoulis GK, Jao W, Gooch GT, et al: Immunohistochemical evaluation of neoplastic and non-neoplastic breast diseases with Mab A-80. Pathol Res Pract 186:439-449, 1990
20. Chejfec G, Candel A, Jansson DS, et al: Immunohistochemical features of giant cell carcinoma of the lung: Patterns of expression of cytokeratins, vimentin and the mucinous glycoprotein recognized by Mab A-80. Ultrastruct Pathol 15:131-138, 1991
21. Eriksson ET, Schimmelpenning H, Rutquist LE, et al: Immunohistochemical expression of the mucin-type glycoprotein A-80 and prognosis in human breast cancer. Br J Cancer 67:1418-1422, 1993
22. Gould VE, Tomanova R, Monson R, et al: Immunophenotypic subsets of large cell pulmonary carcinomas. Lab Invest 70:150A, 1994 (abstr)
23. Kastendieck H: Correlations between atypical primary hyperplasia and carcinoma of the prostate. Pathol Res Pract 169:366-387, 1980
24. Helpap B: The biological significance of atypical hyperplasia of the prostate. Virchows Arch Pathol Anat 387:307-317, 1980
25. McNeal JE, Bostwick DG: Intraductal dysplasia: A premalignant lesion of the prostate. Hum Pathol 17:64-71, 1986
26. Oyasu R, Bahson RR, Nowles K, et al: Cytological atypia in the prostate: Frequency, distribution and possible relevance to carcinoma. J Urol 135:959-962, 1986
27. Bostwick DG, Brawer MK: Prostatic intra-epithelial hyperplasia and early invasion in prostatic cancer. Cancer 59:788-794, 1987
28. McNeal JE: The significance of duct-acinar dysplasia in prostatic carcinogenesis. Prostate 13:91-102, 1988
29. Quinn BD, Cho KR, Epstein JI: Relationship of severe dysplasia to stage B adenocarcinoma of the prostate. Cancer 65:2328-2337, 1990
30. McNeal JE, Villers A, Redwine EA, et al: Microcarcinoma in the prostate: Its association with duct-acinar dysplasia. Hum Pathol 22:644-652, 1991
31. Brawer MK: Prostatic intraepithelial neoplasia: A premalignant lesion. Hum Pathol 23:242-248, 1992
32. Bostwick DG, Amin MB, Dundore P, et al: Architectural patterns of high-grade prostatic intraepithelial neoplasia. HUM PATHOL 24:298-301, 1993
33. Bostwick DG, Srigley J, Grignon D, et al: Atypical adenomatous hyperplasia of prostate: Morphologic criteria for its distinction from well differentiated carcinoma. HUM PATHOL 24:819-832, 1993
34. Helpap BGT, Bostwick DG, Montironi R: The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma. Virchows Arch A Pathol Anat 426:425-434, 1995
35. Brawer MK, Peehl DM, Stamey TA, et al: Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 45:3663-3667, 1985
36. Nagle RB, Brawer MK, Kittelson J, et al: Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. Am J Pathol 138:119-128, 1991
37. O'Malley FP, Grignon DJ, Shum DT: Usefulness of immunoperoxidase staining with high molecular cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland. Virchows Arch A Pathol Anat 417:191-196, 1990
38. Montironi R, Magi Galuzzi C, Diamanti L, et al: Prostatic intraepithelial neoplasia: Qualitative and quantitative analyses of the blood capillary architecture on thin tissue sections. Pathol Res Pract 189:542-548, 1993
39. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
40. Moll R, Lee I, Gould VE, et al: Immunohistochemical analysis of Ewing's tumors: Patterns of expression of intermediate filament and desmosomal proteins indicate cell type heterogeneity and pluripotential differentiation Am J Pathol 127:288-304, 1987
41. Kim YD, Manderino GL, Gooch GT, et al: Isolation and characterization of the tumor-associated mucin-like glycoprotein defined by monoclonal antibody A-80. Cancer Ther Contr 1:277-291, 1991
42. Goldstein NS, Qian J, Bostwick DG: Mucin expression in atypical adenomatous hyperplasia of the prostate. HUM PATHOL 26:887-891, 1995
43. Schellhammer PF, Wright GL: Biomolecular and clinical characteristics of PSA and other candidate prostate tumor markers. Urol Clin North Am 20:597-606, 1993
44. Beard D, Haskell C: Carcinoembryonic antigen in breast cancer. Am J Med 80:241-145, 1986
45. Colcher D, Horan Hand P, Nuti M, et al: Differential binding to human mammary and nonmammary tumors of monoclonal antibodies reactive with carcinoembryonic antigen. Cancer Invest 1:127-128, 1983
46. Coombes RC, Buckman R, Forrester JA, et al: In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer. Cancer Res 46:4217-4220, 1986
47. Cooper EH, Forbes MA, Hancock AK, et al: An evaluation of mucin like carcinoma associated antigen (MCA) in breast cancer. Br J Cancer 59:797-800, 1989
48. Ellis IO, Hinton CP, MacNay J, et al: Immunocytochemical staining of breast carcinoma with a monoclonal antibody NCRC 11: A new prognostic indicator. Br Med J 290:881-883, 1985
49. Ellis IO, Robins RA, Elston CW, et al: A monoclonal antibody, NCRC 11, raised to human breast carcinoma. I. Production and immunohistological characterization. Histopathology 8:501-516, 1984
50. Foster CS, Dindsdale EA, Edwards PAW, et al: Monoclonal antibodies to the human mammary gland. II. Distribution of determinants in breast carcinomas. Virchows Arch A Path Anat 394:295-305, 1982
51. Schlom J, Wunderlich D, Teramoto Y: Generation of human monoclonal antibodies reactive with human mammary carcinoma cells. Proc Natl Acad Sci U S A 77:6841-6845, 1980
52. Stacker SA, Thompson C, Riglar C, et al: A new breast antigen defined by a monoclonal antibody. J Natl Cancer Inst 75:801-811, 1985
53. Thor A, Weeks MO, Schlom J: Monoclonal antibodies and breast cancer. Semin Oncol 13:393-401, 1986
54. Arklie J, Taylor-Papadimitriou J, Bodmer W, et al: Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer 28:23-29, 1981
55. Edwards DP, Grzyb KT, Dressier LG, et al: Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. Cancer Res 46:1306-1317, 1986
56. Hilkens J, Buljs F, Hilgers J, et al: Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer 34:197-206, 1984
57. Teramoto YA, Mariani R, Wunderlich D, et al: The immunohistochemical reactivity of a human monoclonal antibody with tissue sections of human mammary tumors. Cancer 50:241-249, 1981
58. Tjandra JJ, McKenzie IFC: Murine monoclonal antibodies in breast cancer: An overview. Br J Surg 75:1067-1077, 1988
59. Mesa-Tejada R, Palacodety LD, Leon JA, et al: Immunocytochemical distribution of a breast carcinoma associated glycoprotein identified by monoclonal antibodies. Am J Pathol 130:305-314, 1988
60. Ohushi N, Page D, Merino MJ, et al: Expression of tumorassociated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast. J Natl Cancer Inst 79:109-117, 1987
61. Pinkus GS, Kurtin PJ: Epithelial membrane antigen: A diagnostic discriminant in surgical pathology. HUM PATHOL 16:929-940, 1985
62. Moss L, Greenwald D, Cullen B, et al: Cell to cell heterogeneity in the expression of carbohydrate-based epitopes of a mucin-type glycoprotein on the surface of human mammary carcinoma cells. J Cell Physiol (USA) 137:310-320, 1988
63. Burchell J, Gendler S, Taylor-Papadimitriou J, et al: Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 47:5476-5482, 1987
64. Staren ED, Lott S, Muniz-Saavedra V, et al: Neuroendocrine carcinomas of the stomach: A clinicopathologic evaluation. Surgery 112:1039-1047, 1992
65. Hsu W, Deziel DJ, Gould VE, et al: Neuroendocrine differentiation and prognosis of extrahepatic biliary tract carcinomas. Surgery 110:604-611, 1991
66. Bostwick DG: High grade prostatic intraepithelial neoplasia: The most likely precursor of prostate cancer. Cancer 75:1823-1836, 1995